Stop Guessing, Start Validating
The Emerging Pharma Accelerator Toolkit
A practical GTM decision framework that helps pharmaceutical companies validate products, reduce market-entry risk, and improve execution before investing in Southeast Asia or LATAM.
Built from 20 years of real-world international business development experience—not theory
The Problem:
Most international launches don't fail because of the product.
They fail because critical questions were never asked.
Companies often invest months of work and significant regulatory, commercial and business development resources before discovering that:
-
The product cannot be registered.
-
The pricing model is not viable.
-
Distributors have no real incentive to promote it.
-
Margins disappear across the value chain.
-
The selected partner never prioritizes the product.
The Emerging Pharma Accelerator Toolkit was designed to identify these risks before they become expensive mistakes.
What makes this Toolkit different?
This is not another business book. It is a practical decision framework used to challenge assumptions before entering new markets.
Inside you'll find 118 structured questions organised into six decision stages, allowing your team to quickly identify weaknesses, quantify risk and decide whether to proceed, adapt or stop.
Who is this toolkit for?
Ideal for:
-
Business Development Directors
-
International Sales Teams
-
Licensing Managers
-
Export Managers
-
Regulatory Affairs
-
CEOs of pharmaceutical and nutraceutical companies
-
Market Access professionals
What you'll achieve
Instead of relying on assumptions, your team will be able to:
✓ Validate products before investing.
✓ Identify hidden regulatory risks.
✓ Estimate realistic registration timelines.
✓ Assess pricing viability.
✓ Select stronger distributors.
✓ Monitor execution after launch.
✓ Make Go / No-Go decisions with confidence.
Can your team confidently answer these questions before entering a new market?
-
Can this product actually be registered?
-
Will distributors make enough margin?
-
Is one MoQ commercially realistic?
-
Is the registration cost worth the opportunity?
-
Will approval really lead to commercialization?
-
Will your distributor actively promote the product six months after launch?
If any of these questions cannot be answered with evidence—not assumptions—your market entry is already at risk.
Reduce risk before you invest
The Emerging Pharma Accelerator Toolkit gives your team a structured framework to make better international expansion decisions—before time, money and resources are committed.
PRICE: 95 EURO